Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page
- Check3 days agoChange DetectedAdded explicit recruitment status ('No longer looking for participants') and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). Removed the 'Intervention / Treatment' heading and updated the revision label from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check10 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a minor site update to the interface and does not change study data or page content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, replacing the previous revision. This reflects a minor update to the page's revision history and metadata.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s footer revision label has been incremented from v3.5.2 to v3.5.3, indicating a minor software/UI update rather than a change to the underlying clinical trial record.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check75 days agoChange DetectedPublications section updated: replaced the 2025 online-ahead-of-print citation with the 2026 J Thorac Oncol article by Chen MF et al.SummaryDifference0.1%

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.